Results for variability translation from English to Maltese

variability
varjabbiltà ġenetika

variability the capital
variability the capital

high interpatient variability some
varjabilità wiesgħa bejn pazjent u

the variability between subjects was high.
il-varjabilità bejn il-pazjenti kienet għolja.

variability of the capital structure_1
variability of the capital

haemoglobin variability should be addressed ed
il- varjabilità ta ’ l- emoglobina għandha tkun t ot

the variability is increased with high fat food.
il-varjabilità tiżdied b’ikel b’ħafna xaħam.

because of individual variability, titration to ed
id- doża tal- bidu f 'pazjenti tfal ta ’ nespo ta' darba fil- ġimgħa jew ta 'darba kull ġimgħatejn (µg/ ġimgħa) tista' tiġi ddeterminata billi tiddividi d- doża totali ta 'ġimgħa ta' r- huepo (iu/ ġimgħa) b '240.

an increased variability in exposure was also observed.
kienet osservata wkoll żieda fil-varjabbilita` ta’ esponiment.

interindividual variability in systemic clearance is about 15.
il- varjabilità fit-tneħħija sistemika bejn individwu u ieħor hija madwar 15%.

variability of the capital_ ­ confidentiali ­ ty_flag
variability of the capital_ ­ confidentiali ­ ty_flag

to contribute to farm incomes and limit farm income variability
li jkun hemm kontribuzzjoni għall-introjtu agrikolu u tkun limitata l-varjabbiltà tiegħu

food appears to increase pharmacokinetic variability relative to fasting.
l-ikel jidher li jżid il-varjabilità farmakokinetika meta mqabbel mas- sawm.

the inter-individual variability of voriconazole pharmacokinetics is high.
il-varjabilità tal-farmakokinetika ta' voriconazole bejn individwi differenti hija għolja.

however, variability was seen in both c1 hr (day 4 geometric mean
madankollu, dehret varjabilità kemm fil-c1 hr (jum 4 medja ġeometrika 11.73 µg/ml, medda 2.63 sa 22.05 µg/ml) kif ukoll fil-c24 hr (jum 4 medja ġeometrika

between patient variability in clearance is moderate at 19.3 %.
il-varjabilità fit-tneħħija bejn il-pazjenti hija moderata f’perċentwali ta’ 19.3 %.

variability of auc to subcutaneously administered fast-acting human insulin.
f’ pazjenti bid- dijabete mellitus, l- insulina umana inalata kellha varjiabilità ta ’ l- auc fis- suġġetti komparabbli għal insulina umana li taħdem malajr mogħtija taħt il- ġilda.

inter-subject pharmacokinetic variability for pregabalin is low (< 20%).
il- varjabilità fil-farmakokinetika bejn persuna u oħra għal pregabalin hija baxxa (< 20 %).

(where applicable) [warning on the variability of the instalments]
(fejn applikabbli) [twissija dwar il-varjabbiltà tal-pagamenti akkont]

within-subject variability (cvw%) is lower than between-subject variability.
il-varjabilità fi ħdan l-istess individwu (cvw%) hija aktar baxxa mill-varjabilità bejn individwi differenti.